Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 2/20 | 0.66 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.66 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.52 |
| ▸ | HPGD | P15428 | 2/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | ALB | P02768 | 1/20 | 0.47 |
| ▸ | MMP2 | P08253 | 1/20 | 0.47 |
| ▸ | HNF4A | P41235 | 1/20 | 0.44 |
| ▸ | ELANE | P08246 | 2/20 | 0.43 |
| ▸ | CTSG | P08311 | 1/20 | 0.43 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.42 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.42 |
| ▸ | CLCN2 | P51788 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bicarbonate SCHEMBL21836081 | 0.98 | GABRA1 (0.63) | GABRA1GABRB2HMGB1ALDH1A1HPGD | |
| Bicarbonate SCHEMBL236892 | 0.98 | GABRA1 (0.63) | GABRA1GABRB2HMGB1ALDH1A1HPGD | |
| SCHEMBL2165949 | 0.87 | GABRA1 (0.50) | GABRA1GABRB2HMGB1ALDH1A1HPGD | |
| SCHEMBL1552387 | 0.85 | HMGB1 (0.53) | GABRA1GABRB2HMGB1ALDH1A1HPGD | |
| SCHEMBL23642840 | 0.83 | HMGB1 (0.51) | GABRA1GABRB2HMGB1ALDH1A1HPGD | |
| SCHEMBL28460329 | 0.83 | GABRA1 (0.58) | GABRA1GABRB2HMGB1KDM4EHSD17B10 | |
| SCHEMBL23642833 | 0.83 | HMGB1 (0.51) | GABRA1GABRB2HMGB1ALDH1A1HPGD | |
| SCHEMBL157592 | 0.83 | FOLH1 (0.53) | GABRA1GABRB2HMGB1ALDH1A1HPGD | |
| SCHEMBL10782179 | 0.83 | HMGB1 (0.54) | GABRA1GABRB2HMGB1ALDH1A1HPGD | |
| SCHEMBL5172249 | 0.83 | HMGB1 (0.63) | GABRA1GABRB2HMGB1ALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 172 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240400784-A1 | Method for Screening Solvent for Extracting Polyvinyl Chloride, Method for Recycling Waste, Recycled Polyvinyl Chloride, and Composition | LG CHEM, LTD. (KR) | 2024-12-05 | — | — | US | claimed |
| US-20240392094-A1 | Method for Screening Solvent for Polyvinyl Chloride Extraction, Recycling Method for Waste Material, and Recycled Polyvinyl Chloride and Composition | LG CHEM, LTD. (KR) | 2024-11-28 | — | — | US | claimed |
| WO-2023033601-A1 | METHOD FOR SCREENING SOLVENT FOR POLYVINYL CHLORIDE EXTRACTION, RECYCLING METHOD FOR WASTE MATERIAL, AND RECYCLED POLYVINYL CHLORIDE AND COMPOSITION | 주식회사 엘지화학 | 2023-03-09 | — | — | WO | claimed |
| WO-2023033605-A1 | METHOD FOR SCREENING SOLVENT FOR EXTRACTING POLYVINYL CHLORIDE, METHOD FOR RECYCLING WASTE, RECYCLED POLYVINYL CHLORIDE, AND COMPOSITION | 주식회사 엘지화학 | 2023-03-09 | — | — | WO | claimed |
| EP-3452128-B1 | MODIFIED BIODEGRADABLE AND MEDICAL POLYMER DEVICES AND A METHOD FOR PREPARING THE SAME | BEIJING ADVANCED MEDICAL TECH LTD INC (CN) | 2021-10-27 | — | — | EP | claimed |
| EP-2178491-B1 | MIXTURES COMPRISING BENZOTRIAZOLES AND MEROCYANINES | BASF SE (DE) | 2017-03-22 | — | — | EP | claimed |
| US-20160346181-A1 | ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2016-12-01 | — | — | US | claimed |
| WO-2016005149-A1 | LOW-ODOR POLYURETHANE SYSTEMS | EVONIK DEGUSSA GMBH (DE) | 2016-01-14 | — | — | WO | claimed |
| EP-1968531-B1 | TOPICAL COMPOSITIONS FOR REDUCING SKIN IRRITATION | GIVAUDAN SA (CH) | 2014-12-31 | — | — | EP | claimed |
| WO-2014187576-A1 | DEODORIZING ACTIVE INGREDIENT COMBINATION | HENKEL AG & CO. KGAA (DE) | 2014-11-27 | — | — | WO | claimed |
| EP-2020225-B1 | Fragrance composition | KAO CORP (JP) | 2014-10-08 | — | — | EP | claimed |
| US-20120184513-A1 | Organic Compounds | GIVAUDAN SA (CH) | 2012-07-19 | — | — | US | claimed |
| EP-2211829-B1 | IMPROVEMENT OF THE FRAGRANCE EFFECT OF PERFUME ESTERS | HENKEL AG & CO KGAA (DE) | 2011-04-27 | — | — | EP | claimed |
| EP-2211829-A1 | IMPROVEMENT OF THE FRAGRANCE EFFECT OF PERFUME ESTERS | Henkel AG & Co. KGaA (DE) | 2010-08-04 | — | — | EP | claimed |
| US-20100063011-A1 | Organic compounds | GIVAUDAN SA (CH) | 2010-03-11 | — | — | US | claimed |
| WO-2009059858-A1 | IMPROVEMENT OF THE FRAGRANCE EFFECT OF PERFUME ESTERS | HENKEL AG & CO. KGAA (DE) | 2009-05-14 | — | — | WO | claimed |
| EP-1968531-A2 | TOPICAL COMPOSITIONS FOR REDUCING SKIN IRRITATION | Givaudan SA (CH) | 2008-09-17 | — | — | EP | claimed |
| WO-2007030961-A2 | TOPICAL COMPOSITIONS FOR REDUCING SKIN IRRITATION | GIVAUDAN SA (CH) | 2007-03-22 | — | — | WO | claimed |
| WO-2025228904-A1 | LAYER STRUCTURE WITH AT LEAST TWO LAYERS HAVING DIFFERENT ENGRAVINGS | COVESTRO DEUTSCHLAND AG (DE) | 2025-11-06 | — | — | WO | disclosed |
| EP-0045861-A2 | Unsaturated compounds, process for their preparation, their use as perfumes and the perfumed compositions containing them | L. GIVAUDAN & CIE Société Anonyme (CH) | 1982-02-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100063011-A1 | Organic compounds | CYP1A1, CYP1B1, OXER1 | GABRA1 3492/4885GABRB2 3369/4885HMGB1 299/4885 |
| US-20120184513-A1 | Organic Compounds | CYP1A1, CYP1B1, OXER1 | GABRA1 3492/4885GABRB2 3369/4885HMGB1 299/4885 |
| US-20160346181-A1 | ORGANIC COMPOUNDS | CYP1A1, CYP1B1, OXER1 | GABRA1 3492/4885GABRB2 3369/4885HMGB1 299/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.